Active Tuberculosis Clinical Trial
Official title:
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
There was no sensitive and specific biomarker for tuberculosis infection, disease progression and predicting the prognosis of treatment. Therefore, the investigators aimed to investigate and evaluate the newer biomarker for the diagnosis of TB infection. To investigate the new biomarker for TB infection, the investigators will recruit the participants including active TB patients, healthy household contacts, healthy community control.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT05048381 -
miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)
|
||
| Completed |
NCT03271567 -
Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
|
||
| Not yet recruiting |
NCT02512484 -
Improving the Detection of Active Tuberculosis in Accident and Emergency Departments
|
N/A | |
| Completed |
NCT06408129 -
COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB)
|
||
| Completed |
NCT02042261 -
The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study
|
N/A | |
| Active, not recruiting |
NCT05045391 -
Pulmonary Aspergillosis in Tuberculosis Patients
|
||
| Completed |
NCT04048018 -
Performance Evaluation of the VIDAS TB-IGRA Assay.
|
||
| Recruiting |
NCT02639936 -
New Generation IGRA in Immunocompromised Individuals
|
N/A | |
| Terminated |
NCT02898623 -
Serological Test for the Diagnosis of TB
|